Table 2.

Summary of FISH findings for 11;14, 4;14, and p53




Successful determination, no. of patients

Patients with translocation or deletion, no. (%)

Overall survival with/without abnormality, median no.

Progression-free survival with/without abnormality, median mo.
t(11;14)(q13;q32)   197   34 (17)   36.6/34.8   20.1/15.3  
−17p13.1 (TP53)   168   18 (11)   15.1/38.8*  8.7/16.1* 
t(4;14)(p16.3;q32)   153   26 (17)   18.8/43.9  8.2/17.8 
t(4;14)+(p16;q32)Δ13
 
84
 
22 (26)
 
18.8/26.8*
 
8.2/12.9
 



Successful determination, no. of patients

Patients with translocation or deletion, no. (%)

Overall survival with/without abnormality, median no.

Progression-free survival with/without abnormality, median mo.
t(11;14)(q13;q32)   197   34 (17)   36.6/34.8   20.1/15.3  
−17p13.1 (TP53)   168   18 (11)   15.1/38.8*  8.7/16.1* 
t(4;14)(p16.3;q32)   153   26 (17)   18.8/43.9  8.2/17.8 
t(4;14)+(p16;q32)Δ13
 
84
 
22 (26)
 
18.8/26.8*
 
8.2/12.9
 

FISH indicates fluorescence in situ hybridization.

*

p ≤.01.

p < .001.

or Create an Account

Close Modal
Close Modal